Skip to main content

Advertisement

Table 1 Baseline Characteristics of the cohort/all patients

From: Low molecular weight heparins use in pregnancy: a practice survey from Greece and a review of the literature

CharacteristicN = 818
Age (mean ± SD)33.9 ± 4.9
BMI (mean ± SD)24.5 ± 4
No. of fetuses at observed gestation (N, %)
 1767 (93.8)
  ≥ 251 (6.2)
 Delivery by CS (N, %)644 (78.7)
Reason for enrolling in the study
 Group A: History of VTE (DVT/SVT/Arterial thrombosis/Arterial Ischemia)76 (9.3%)
 Group B: History of Pregnancy complications445 (54.4%)
 Group C: IVF132 (16.1%)
 Group D: Other reasons165 (20.2%)
Mean Duration of LMWH (months) (mean ± SD)8.6 ± 1.5
Concomitant Use of ASA (N, %)152 (18.6)
Mean Duration of ASA (months) (mean ± SD)6.2 ± 2.7